APR 03, 2021 7:06 AM PDT

New factor plays a key role in immune response

In a study published recently in Science Immunology, WEHI’s Professor Stephen Nutt, Dr. Michael Chopin, and Mr. Shengbo Zhang have established the differentiation process that triggers the immune system to control cancer and infectious disease. The process identifies how a factor they’re calling DC-SCRIPT is necessary to trigger dendritic cells called cDC1 to produce an immune response.

The study explains how DC-SCRIPT is involved in producing the dendritic cells responsible for an immune reaction. Dendritic cells are immune cells that activate 'killer' T cells, the immune cells that attack viral infections elicit a response to tumors.

The researchers say that this knowledge will help the scientific and medical communities guide future investigations that aim to stimulate the human body to generate large numbers of dendritic cells, thus allowing for improved reactions to fight off cancer and infections.

"What we found, is that without this new factor, the cells develop poorly, and their capacity to fight infection and cancer, or to clear a parasite, is diminished," notes Professor Nutt. "The next stage of our research is to try and work out how we can get the body to produce these particular dendritic cells, cDC1s, in large volumes in order to boost the body's natural tumor response."

Dr. Chopin adds that cDC1s represent the potential to enhance immunity to viruses and tumors. "This paper clearly shows DC-SCRIPT is one of the regulators of dendritic cell production. As a result of this study, we're now focussed on ways we could harness this to increase dendritic cell production," he said. "We now have a biomarker to follow when we expand this elusive cell type, which we will continue to test in pre-clinical models. We have generated new tools, allowing us to trace these cells within the tumor and observe how they behave in the tumor environment.”

Sources: Science Immunology, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAR 12, 2021
Drug Discovery & Development
Drug Starves Melanoma Tumors
MAR 12, 2021
Drug Starves Melanoma Tumors
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake ...
APR 02, 2021
Cancer
Missing link identified for "bad" cholesterol
APR 02, 2021
Missing link identified for "bad" cholesterol
New research from a team at the University of Alberta has identified the protein that is associated with low-density lip ...
APR 12, 2021
Cancer
Using antibodies to treat melanoma
APR 12, 2021
Using antibodies to treat melanoma
New research presented at the American Association of Cancer Research (AACR) virtual annual meeting this week from the Y ...
MAY 05, 2021
Cancer
Developing Therapies to Combat Drug-Resistant Cell States
MAY 05, 2021
Developing Therapies to Combat Drug-Resistant Cell States
Drug resistant tumors present challenges in cancer treatment A significant challenge in the treatment of cancers is the ...
MAY 23, 2021
Neuroscience
Study Links Alcohol Consumption to a Decline in Brain Health
MAY 23, 2021
Study Links Alcohol Consumption to a Decline in Brain Health
Thinking of cracking open a cold one this weekend? Researchers from the University of Oxford have identified a connectio ...
JUN 05, 2021
Cancer
How is the new hospital price transparency rule going?
JUN 05, 2021
How is the new hospital price transparency rule going?
New findings from an analysis of hospital price transparency have been published recently in JAMA. The analysis was ...
Loading Comments...